EAM
GILD icon

Erste Asset Management’s Gilead Sciences GILD Stock Holding History

Erste Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.8M Sell
426,561
-121,272
-22% -$16M 0.42% 50
2026
Q1 		$74.8M Buy
547,833
+73,366
+15% +$10.3M 0.69% 36
2025
Q4 		$59.2M Buy
474,467
+27,625
+6% +$3.36M 0.5% 50
2025
Q3 		$50.3M Sell
446,842
-30,299
-6% -$3.44M 0.49% 55
2025
Q2 		$52.7M Buy
477,141
+83,048
+21% +$8.84M 0.44% 54
2025
Q1 		$44.1M Buy
394,093
+2,319
+0.6% +$239K 0.57% 52
2024
Q4 		$36.9M Sell
391,774
-18,055
-4% -$1.63M 0.45% 61
2024
Q3 		$34.3M Buy
409,829
+2,175
+0.5% +$166K 0.41% 67
2024
Q2 		$28.1M Buy
407,654
+2,785
+0.7% +$186K 0.37% 75
2024
Q1 		$29.6M Sell
404,869
-11,333
-3% -$871K 0.4% 73
2023
Q4 		$33.8M Buy
416,202
+26,249
+7% +$2.04M 0.49% 62
2023
Q3 		$29.4M Buy
389,953
+3,865
+1% +$297K 0.51% 64
2023
Q2 		$29.4M Sell
386,088
-83,502
-18% -$6.66M 0.52% 57
2023
Q1 		$38.2M Sell
469,590
-36,100
-7% -$2.99M 0.73% 40
2022
Q4 		$43.1M Buy
505,690
+63,978
+14% +$5.07M 0.91% 28
2022
Q3 		$27.9M Buy
441,712
+14,247
+3% +$898K 0.62% 46
2022
Q2 		$26.7M Buy
427,465
+12,418
+3% +$769K 0.59% 46
2022
Q1 		$24.8M Buy
415,047
+2,959
+0.7% +$189K 0.47% 63
2021
Q4 		$30.3M Buy
412,088
+29,164
+8% +$2.01M 0.55% 56
2021
Q3 		$27.2M Buy
382,924
+11,173
+3% +$785K 0.54% 58
2021
Q2 		$25.3M Sell
371,751
-5,459
-1% -$365K 0.5% 61
2021
Q1 		$24.7M Buy
377,210
+15,390
+4% +$992K 0.6% 52
2020
Q4 		$20.6M Buy
361,820
+10,460
+3% +$631K 0.57% 49
2020
Q3 		$21.8M Sell
351,360
-36,860
-9% -$2.56M 0.74% 36
2020
Q2 		$29.1M Buy
388,220
+74,015
+24% +$5.67M 1.16% 14
2020
Q1 		$23.7M Buy
314,205
+94,495
+43% +$6.53M 1.38% 13
2019
Q4 		$14.5M Sell
219,710
-63,745
-22% -$4.15M 0.64% 41
2019
Q3 		$17.8M Buy
283,455
+1,515
+0.5% +$99K 0.95% 27
2019
Q2 		$18.9M Sell
281,940
-18,500
-6% -$1.22M 1% 25
2019
Q1 		$19.1M Buy
300,440
+148,800
+98% +$9.89M 1.07% 22
2018
Q4 		$9.54M Buy
+151,640
New +$10.6M 0.64% 33

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Erste Asset Management's GILD Position: Q2 2026 in Review

Erste Asset Management reduced its Gilead Sciences (GILD) stake by 22% in Q2 2026, selling an estimated $16M and leaving 426,561 shares worth $53.8M. The position accounts for 0.42% of the portfolio, ranked #50.

Erste Asset Management first reported a position in GILD in Q4 2018 and has held it in 31 quarters since. The position peaked at $74.8M in Q1 2026. 965 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Erste Asset Management held 426,561 shares of Gilead Sciences worth $53.8M as of Q2 2026.
  • Erste Asset Management sold 121,272 Gilead Sciences shares in Q2 2026, an estimated $16M.
  • Gilead Sciences made up 0.42% of Erste Asset Management's portfolio in Q2 2026, its #50 holding.
  • Erste Asset Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 31 quarters since.
  • Erste Asset Management's Gilead Sciences position peaked at $74.8M in Q1 2026.
  • 965 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.